Compare Jakarta International Hotels Development Tbk (JIHD) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jakarta International Hotels Development Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Jakarta International Hotels Development Tbk trades at Rp430 (market cap 987.51B, 401.3K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 11.5× Jakarta International Hotels Development Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.77M versus 401.3K). Which is the better fit depends on your goals.
| JIHD | TSPC | |
|---|---|---|
Market Cap | 987.51B | 11.36T |
Volume | 401.3K | 1.77M |
Lot | 4.01K | 17.71K |
Turnover | 173.08M | 4.61B |
Average Price | 431.29 | 2,603.9 |
Value | 173.08M | 4.61B |
Indicative Equilibrium Price | 430 | 2,590 |
Indicative Equilibrium Volume | 25 | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jakarta International Hotels Development Tbk
PT Jakarta International Hotels and Development Tbk (the Company) was established on November 7, 1967. The Company is the owner of Hotel Borobudur (“the Hotel”) which had been managed and operated by Inter-Continental Hotels (Indonesia) BV (Operator) until December 31, 1998. Starting January 1, 1999, the Hotel has been operated by PT Dharma Harapan Raya 60% of whose shares are owned by the Company.
Read more on JIHD →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
